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Abstract 
For the evaluation of performance at the national level are used the different indicators in comparison with business level. The
paper is focused on evaluation of indicators of national health systems’ performance at the level WHO “better health”. The aim 
of paper is to define the specifics of selected health systems in European Union, analyze and evaluate the selected indicators of 
performance of these systems which are used by WHO, compare the results of the analysis in these health systems and determine 
the position of the Czech health system in the set of indicators “better health” in comparison with other countries. The indicators
are evaluated in the time series. 
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1. Introduction 
Today, healthcare systems in all over the world play a prominent role in people’s life than ever before. The main 
goal of health systems is to improve the health of the individuals. The current health systems have many highly 
skilled people and better technologies what give the health system the power and the potential to achieve further 
extraordinary improvements. On the other hand, the new possibilities in health care sector are not only positive. The 
many health systems cannot use all of their potential. The health system we can often name as poorly structured, 
badly led, inefficiently organized and inadequately funded. So it is necessary to manage these systems and evaluate 
their performance. 
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The ultimate responsibility for the overall performance of a country’s health system lies with government. By 
reason of this is the fact that health care has many impacts on economics and it is the very important determinant of 
economic growth. Providing the people’s health has a national priority and government have permanent 
responsibility against them. Therefore, Health Ministry has a big part in the health system stewardship. Healthcare 
policies and strategies need to cover the private provision of services and private financing as well as state funding 
and activities.  
There is continuous probe to improve our understanding of conditions that make the public health services 
effective. We know that public health plays an important role in social sciences and social praxes. How mentioned 
(Szreter & Woolcock, 2004) there are many discussions about relationship between social capital and public health.  
Better health is unquestionably the primary goal of a healthcare system. It can be costly; therefore, the need for 
having unpredictable mechanisms for sharing risk and providing financial protection seems necessary. The second 
aim of providing such systems is fairness in financial contribution to the health system. responsiveness to people’s 
expectations with regard to non-health matters – reflects the importance of respecting people’s dignity, autonomy 
and the confidentiality of information (World Health Organization, 2000). 
2. Methodology, research questions and data 
The aim of this paper is to define the specifics of selected health systems in European Union, analyze and 
evaluate the selected indicators of performance of these systems which are used by World Health Organization, 
compare the results of the analysis in these health systems and determine the position of the Czech health system in 
the set of indicators “better health” in comparison with other countries.  
The paper answers mainly these questions: What is position of the Czech health system at the level WHO “better 
health” in comparison of other European health system? What results bring the selected indicators and how we can 
interpret these indicators? The answers to these questions are based on literature review, from results calculation of 
performance indicators and statistics methods, one of used method is Granger Causality Test.  The data for this paper 
are used from WHO data, the OECD Health Data, Eurostat database of the health care expenditure and scientific 
papers. The indicators are evaluated in the time series. The selected countries were chosen by reason of their similar 
principles of health systems which are characteristic by the same main source of funding – health insurance. The 
paper is compared indicators of 10 countries. 
3. Health systems 
Many research studies mentioned that the health is the important factor of the economic growth; see for example 
Lucas (1988), Sala-i-M. (1996). This fact is widely recognized public policy of all developed countries and by 
reason of this fact we have to solve problem of health on the level of national economies and after than we can speak 
about the term “health system”. A good healthcare system provides qualified services to all people when and where 
they require them. The exact shape of services differs in various countries, but all cases needs a huge financing 
mechanism, well-trained workforce, and reliable information.  
A healthcare system consists of different parts. In addition to patients, families, and communities, Ministries of 
Health, health providers, health services organizations, pharmaceutical companies, health financing bodies, and other 
organizations play prominent roles. The interconnections of the health system can be viewed as the functions 
including oversight, health service provision, financing, and managing resources. Describing the parts, 
interconnections, and purpose, Roemer (2002) defined a health system as “the combination of resources, 
organization, financing and management that culminate in the delivery of health services to the population.” The 
World Health Organization (2000) redefined the main purpose in its definition of a health system as “all activities 
whose primary purpose is to promote, restore, and maintain health.” In recent years, the definition of “purpose” has 
been further extended to include the prevention of household poverty due to illness (World Bank, 2007). How 
mentioned Plsek and Greenhalgh (2001) the health system is complex adaptive system which has important 
implications for approaches to influencing health systems to produce better health outcomes, or to do so in a more 
efficient or equitable manner. 
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From the perspective of the long-term sustainability and development the health system has to have a certain 
concept. According to Kelley and Hurst (2006) the conceptual framework of current health system has to include the 
following indicators: efficiency, security, ability to respond, availability, equity and effectiveness. 
As mentioned Physicians for a National Health Program (2010) there are four basic models of the health system 
from the perspective of type of finance and manage of health care: Beveridge model (the health care is provided and 
financed by the government through tax payments), Bismarck model (this model is based on social insurance), 
National Health Insurance (model has elements of both Beveridge and Bismarck models) and Out-of-Pocket model 
(this model could be called “market driven” health care; the most expensive activities are paid by consumer of health 
care).
There are many differences in the allocation of resources from the perspective of public and private payments in 
European countries. It is necessary to point out the fact that nowadays costs of health care funding are influenced by 
demographic change, pressure for higher quality care and increased costs by reason of emergence of new diseases 
(Hejduková, 2015). So many health care systems in Europe can be identified as the mix health care models with 
some dominant source of funding. 
4. Selected countries and indicators for performance evaluation of their health system 
4.1. Selected countries 
Across all OECD countries, health care is financed by a mix of public and private spending. In some countries, 
public health spending is mostly confined to spending by the government using general revenues. In other cases, 
social insurance funds finance the bulk of health expenditure. Private financing of health care consists mainly of 
payments by households (either as standalone payments or as part of co-payment arrangements) as well as various 
forms of private health insurance (OECD, 2015). 
How mentioned (Xu et al., 2011) the OECD study recognized that health expenses per capita income was higher 
in countries which have a social health insurance mechanism. There are a few empirical studies about financing 
structures which determine the healthcare expenses was financed by the government has a relationship with levels of 
healthcare system’s expenses (Culyer, 1988; Hitiris & Posnett, 1992; Leu, 1986; van der Gaag & Stimac, 2008). 
There are differences between tax-based and social-insurance based systems which were used in OECD countries 
and eastern European and central Asian countries (Wagstaff, 2009; Wagstaff & Moreno-Serra, 2009).  
We have chosen for our analysis these 10 countries: Belgium, Czech Republic, Estonia, France, Luxembourg, 
Germany, Nederland, Poland, Slovakia and Slovenia. The reason of this selection is the fact that these countries 
have the same main source of the health care funding. The public insurance is contributed in the total health 
expenditure between 60 – 80 % in these countries – see Table 1 (OECD, 2015). 
     Table 1. The share of the social insurance in the total health expenditure in selected countries in 2015. 
Country The share of social insurance of health expenditure  
Belgium 66% 









Although these selected countries show the same main source of health care funding, we can see the differences 
in health expenditure in relation to GDP – see Table 2 (Eurostat, 2016). 
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     Table 2. The health care expenditure as the share of GDP in selected countries in 2005 – 2010 (in %). 
Country 2005 2006 2007 2008 2009 2010 
Belgium 9,65 9,58 9,62 9,94 10,65 10,56 
Czech Republic 6,69 6,49 6,31 6,65 7,63 7,24 
Estonia 4,99 4,97 5,08 5,81 6,65 6,27 
France 10,50 10,41 10,35 10,48 11,17 11,13 
Luxembourg 10,40 10,26 10,12 10,33 11,33 11,15 
Germany 7,13 6,69 6,18 6,67 7,63 7,19 
Nederland 10,09 9,97 9,96 10,20 11,01 11,20 
Poland 5,85 5,85 5,93 6,43 6,72 6,55 
Slovakia 6,75 7,02 7,38 7,63 8,61 8,48 
Slovenia 7,96 7,79 7,49 7,88 8,59 8,58 
4.2. Definition of concrete selected indicators 
For the definition and evaluation of performance were chosen the following indicators including life expectancy 
at birth, potential years of life lost, disability-adjusted life expectancy, and healthcare expenditure or expenses. 
5. Analysis and results 
Four indicators and their evaluation over time were chosen for the further analysis. The selected indicators are: (i) 
Life expectancy at birth ("LE"), (ii) Potential years of life lost ("PYLL"), (iii) Disability-adjusted life expectancy 
("DALE") and (iv) Health care expenditure („EXP“). These indicators were used to compare and to describe their 
developments over time and within selected Europe countries. Then it is examined the statistical hypothesis test for 
determining whether health care expenditure  is useful in forecasting two indicators: „LE“ and „PYLL“. The 
Granger causality test is used for this examination. The period from 2000 to 2013 was selected as a reference period 
for further analysis, but unfortunately not all data were complete, that is why we had to reduce examined period for 
Granger causality test. So the period for testing Granger causality contains years from 2005 to 2010. As a data 
source were used European Health for All Database (HFA-DB), OECD Health statistics (Health status) and Eurostat 
database (hlth_sha_hp). 
5.1. Comparison of indicators over time and within countries 
The simple indexes of time series dynamics were calculated for examination and evolution. Two indexes were 
used for description of the development of indicators over time: (i) relative change and (ii) the geometric mean. 
Furthermore it was graphically demonstrated the absolute trend of individual indicators (see Fig. 1 and Fig. 2). 
244   Pavlína Hejduková and Lucie Kureková /  Procedia - Social and Behavioral Sciences  230 ( 2016 )  240 – 248 




Growth 2000 - 
2010




Growth 2000 - 
2010
Trend 2000 - 2013*
Belgium 3.01% 0.28% -21.37% 2.09%
Czech Republic 3.46% 0.34% -23.47% 2.56%
Estonia 7.16% 0.68% -41.27% 5.05%
France 3.31% 0.33% -20.18% 2.20%
Germany 2.83% 0.29% -22.32% 2.48%
Luxembourg 3.06% 0.29% -28.52% 2.67%
Netherlands 3.65% 0.35% -26.46% 2.88%
Poland 3.68% 0.41% -20.43% 2.64%
Slovakia 3.01% 0.30% -21.07% 2.42%
Slovenia 4.84% 0.49% -33.08% 3.94%
Source
Legend <0-33) 32 <33-67) 33 <67-100> 67
* Note:
 data for SK and SL available only t ill 2010.  data for SK and SL available only till 2010.
 data for FR available only till 2011.
data for BE available only till 2012 data for BE available only till 2012
HFA-DB Health status
Life expectancy at birth (years) Potential years of life lost
 data for EE and FR available only till 2011.
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Fig. 2. Development of selected indicators in time. 
Relative change expresses the absolute change as a percentage of the value of the indicator in the earlier period. 
Relative change also refers to the change in the indicator in percentage terms, i.e. absolute change as a percent-age 
of the value of the indicator in period one. The geometric mean is a measure of mean that indicates the typical value 
of a set of numbers. The geometric mean is referred to as compounded annual growth rate or time-weighted rate of 
return and it is the average rate of return of a set of values calculated using the products of the terms (see more Arlt 
& Arltová, 2009). 
We expected that indexes of first LE were positive; it is mean that life expectancy grew over time. The highest 
increased was in Estonia and it raised by almost 7.16 % between 2000 and 2010. The supreme LE was in France and 
reached the amount of 81.98 years, in Estonia it was 76.03 years. In the Czech Republic LE was 77.81 years and 
compared to selected countries only Poland and Slovakia were lower LE. If we look at the average growth over time 
and, of course, the highest average growth was in Estonia and then Slovakia, the smallest average growth was in 








Growth 2005 - 
2010
Trend 2003 - 2012*
Belgium 2.92% NA 23.66% 4.18%
Czech Republic 3.93% NA 51.30% 9.52%
Estonia 8.06% NA 21.34% 3.73%
France 3.31% NA 64.46% 10.96%
Germany 3.19% NA 16.01% 3.07%
Luxembourg 4.22% NA 20.28% 3.75%
Netherlands 3.48% NA 24.78% 6.31%
Poland 3.72% NA 62.46% 11.50%
Slovakia 4.22% NA 114.56% 16.50%
Slovenia 5.15% NA 29.94% 5.39%
Source





 data for SI vailable only till 2011.
 data for SK vailable only from 2005 till 2011.* Note:
data available only for years 2000, 2012 
and 2013
Disability-adjusted life expectancy 
HFA-DB
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For PYLL indicator, we should expect negative values for calculated indexes, our expectations are demonstrated 
in Table 3 (note Growth 2000 - 2010 is expressed in absolute terms). Again, we can see that the biggest relative 
change was in Estonia. In 2010 the absolute value of the PYLL was lowest in the Netherlands: 2737.6 and the 
highest was one in Estonia: 5,623.7. The Czech Republic was doing better than Slovakia in terms of comparison of 
absolute value (CZE: 3942.2 and SK: 5113.9). The indicator DALE is measured in years as well as LE and again we 
expected that should grow over time. The most rapid growth was observed in Estonia and in Slovenia. The same 
relative change was in Slovakia and Luxembourg. The absolute value of DALE was in France, it is same for LE, and 
the lowest absolute value of DALE was again in Slovakia (66.7 years). 
The last but not the least important indicator is health care expenditure per inhabitant and it is used for more 
complex depicting of the performance of health care system (see Granger causality test). The data of selected 
countries were available for period since 2003 and the latest published data for international comparisons were for 
the year 2012. The data for reference time period unfortunately are not complete for all analyzed countries. The 
absolute values of variable EXP in 2011 were highest in the countries of Benelux (LUX: 5 661 Euro per inhabitant, 
NED: 4 037 Euro per inhabitant, BEL 3 562 Euro per inhabitant). The lowest absolute value of EXP were 
surprisingly pursued in France 702 Euro per inhabitant, in the Czech Republic EXP amounted 1 091 Euro per 
inhabitant. Dynamics indexes were calculated for the years 2005-2010, this period was also used for testing Granger 
causality. The highest relative change of EXP were in the Slovakia namely by 115%, and quite high increase in 
expenditure was in France and Poland. The smallest increase was in Germany. Quite surprisingly EXP did not grow 
much in Estonia. 
5.2. Granger causality test 
As we mentioned above, for creating a balanced panel data set was chosen period from 2005 to 2010, this data set 
contains 60 observations. It was necessary to find out whether the time series is stationary. It was used the 
augmented Dickey–Fuller test (ADF test), unfortunately at 5% significance level was not possible to reject the null 
hypothesis. It means that time series variables are non-stationary; hence it was necessary to adjust the time series to 
be stationary. For stationarizing time series variables were used first differences and then logarithmic 
transformation. This transformed time series were finally stationary and two tests of Granger causality were applied. 
Granger causality test helped us to find out whether expenditures on health care EXP explain the development of 
selected indicators (PYLL and LE). Two null hypotheses were tested: H0: Percentage change of EXP did not cause 
percentage change of PYLL and H0: Percentage change of EXP did not cause percentage change of LE.  
     Table 3. Results of Granger causality tests. 
Equation Exluced F df df_r Prob > F 
LE Exp 2.3684 2 43 0.1057 
PYLL Exp 0.67184 2 43 0.516 
According results in Table 3, it is clear that the at the 5% significance level we are not able to reject both null 
hypothesis. Thus we are able to claim according these data that the percentage change in EXP did not cause 
percentage change in the indicators LE and PYLL. 
6. Conclusion 
There are many variants of the health care systems in the world. Many differences we can found also in Europe. 
In some countries, public health spending is mostly confined to spending by the government using general revenues. 
In other cases, social insurance funds finance the bulk of health expenditure. Private financing of health care 
consists mainly of payments by households (either as standalone payments or as part of co-payment arrangements) 
as well as various forms of private health insurance (OECD, 2015). 
There were chosen countries with health systems for which are typical the social health insurance. However these 
health systems represented by these indicators show quite huge differences in dynamic changes over time. From the 
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perspective of the share of social insurance in the total health expenditure, the Czech Republic has the second 
highest the share of social insurance in total health expenditure in comparison with other analyzed countries. The 
health care expenditure as a percentage of GDP were 7,24 % in 2010 in the Czech Republic  it means that the Czech 
Republic can be classified like the country with quite small share of health expenditure of GDP. On the other hand, 
from the perspective of the health expenditure per habitant, the Czech Republic shows one of the greatest growth 
between 2005 – 2010.  
The growth of indicator “Life expectancy at birth” was quite small in the Czech Republic in comparison with 
other analyzed countries. The same results we can see for indicator “Potential years of life lost” which is declined 
over time and this decrease was also the one of the smallest. The relative change of indicator “Disability-adjusted 
life expectancy” was 3.93 % in the Czech Republic and this value is similar for France, Luxembourg and Slovakia. 
There was set the question in the paper, if health care expenditure can cause the changes in the indicators PYLL 
and LE. Granger causality test helped us to find out whether expenditures on health care EXP explain the 
development of selected indicators (PYLL and LE). According results, we are able to claim that the percentage 
change in expenditure did not cause percentage change in the indicators LE and PYLL. 
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